glp 1 cardiovascular disease and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia The cardiovascular effects of GLP-1

Effects on lipoprotein particles of long-term dehydroepiandrosterone in elderly men and women and testosterone in elderly men

Yes, GLP-1 receptor agonists and thyroid medications can generally be used together, but concurrent use requires clinical awareness and provider monitoring

Most of this weight loss occurs within the first 68 to 72 weeks of treatment, so patience and consistency are key

Systematic reviews and meta-analyses of randomized controlled trials have found that GLP-1 receptor agonists significantly decreased CRP levels compared to placebo or other diabetes medications

It is also important to note that combination weight loss products are brand name but are sometimes split into their generics by practitioners, an off-label method of getting similar doses and weight loss at a lower cost